MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/21/2025ACC: 0001415889-25-014025
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
+729.00
Net shares
Net buyer
$91.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
10.43K acquired · 9.70K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+10.43K
Price / share
—
Trade value
—
% of position
4.9%
5/19/2025
214.26K→224.69K
Ordinary Shares
Direct
Shares
−9.70K
Price / share
$9.45
Trade value
$91.67K
% of position
4.3%
5/20/2025
224.69K→214.99K
Total
Net shares
+729.00
Net value
-$91.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/19/2025 | A · Award | +10.43K | — | — | 4.9% | 214.26K | 224.69K |
| Ordinary Shares Direct | 5/20/2025 | F · Tax Withholding | −9.70K | $9.45 | $91.67K | 4.3% | 224.69K | 214.99K |
| Total | +729.00 | -$91.67K | ||||||
Derivative Transactions0
No derivative transactions reported